% alzhub.org library filter
% Source: https://alzhub.org/research?institution=I4210151718
% 60 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{swanson2021-33865446,
  author  = {Swanson, C. J. and Zhang, Y. and Dhadda, S. and Wang, J. and Kaplow, J. and Lai, R. Y. K. and Lannfelt, L. and Bradley, H. and others},
  title   = {{A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00813-8},
  pmid    = {33865446},
  url     = {https://doi.org/10.1186/s13195-021-00813-8}
}

@article{vandyck2023-36449413,
  author  = {van Dyck, C. H. and Swanson, C. J. and Aisen, P. and Bateman, R. J. and Chen, C. and Gee, M. and Kanekiyo, M. and Li, D. and others},
  title   = {{Lecanemab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2023},
  doi     = {10.1056/nejmoa2212948},
  pmid    = {36449413},
  url     = {https://doi.org/10.1056/nejmoa2212948}
}

@article{honig2024-38730496,
  author  = {Honig, L. S. and Sabbagh, M. N. and van Dyck, C. H. and Sperling, R. A. and Hersch, S. and Matta, A. and Giorgi, L. and Gee, M. and others},
  title   = {{Updated safety results from phase 3 lecanemab study in early Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01441-8},
  pmid    = {38730496},
  url     = {https://doi.org/10.1186/s13195-024-01441-8}
}

@article{teng2022-35696185,
  author  = {Teng, E. and Manser, P. T. and Pickthorn, K. and Brunstein, F. and Blendstrup, M. and Sanabria Bohorquez, S. and Wildsmith, K. R. and Toth, B. and others},
  title   = {{Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.1375},
  pmid    = {35696185},
  url     = {https://doi.org/10.1001/jamaneurol.2022.1375}
}

@article{shcherbinin2022-36094645,
  author  = {Shcherbinin, S. and Evans, C. D. and Lu, M. and Andersen, S. W. and Pontecorvo, M. J. and Willis, B. A. and Gueorguieva, I. and Hauck, P. M. and others},
  title   = {{Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.2793},
  pmid    = {36094645},
  url     = {https://doi.org/10.1001/jamaneurol.2022.2793}
}

@article{jansen2022-36066633,
  author  = {Jansen, I. E. and van der Lee, S. J. and Gomez-Fonseca, D. and de Rojas, I. and Dalmasso, M. C. and Grenier-Boley, B. and Zettergren, A. and Mishra, A. and others},
  title   = {{Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers}},
  journal = {Acta neuropathologica},
  year    = {2022},
  doi     = {10.1007/s00401-022-02454-z},
  pmid    = {36066633},
  url     = {https://doi.org/10.1007/s00401-022-02454-z}
}

@article{devanand2026-41405855,
  author  = {Devanand, D P and Wisniewski, Thomas and Razlighi, Qolamreza and Qian, Min and Wei, Renjie and Andrews, Howard F and Acosta, Edward P and Bell, Karen L and others},
  title   = {{Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2026},
  doi     = {10.1001/jama.2025.21738},
  pmid    = {41405855},
  url     = {https://doi.org/10.1001/jama.2025.21738}
}

@article{rogers1998-9588436,
  author  = {Rogers, S. L. and Doody, R. S. and Mohs, R. C. and Friedhoff, L. T.},
  title   = {{Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group}},
  journal = {Archives of internal medicine},
  year    = {1998},
  doi     = {10.1001/archinte.158.9.1021},
  pmid    = {9588436},
  url     = {https://doi.org/10.1001/archinte.158.9.1021}
}

@article{dichgans2008-18296124,
  author  = {Dichgans, M. and Markus, H. S. and Salloway, S. and Verkkoniemi, A. and Moline, M. and Wang, Q. and Posner, H. and Chabriat, H. S.},
  title   = {{Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL}},
  journal = {The Lancet. Neurology},
  year    = {2008},
  doi     = {10.1016/s1474-4422(08)70046-2},
  pmid    = {18296124},
  url     = {https://doi.org/10.1016/s1474-4422(08)70046-2}
}

@article{hu2022-35446396,
  author  = {Hu, Y. and Kirmess, K. M. and Meyer, M. R. and Rabinovici, G. D. and Gatsonis, C. and Siegel, B. A. and Whitmer, R. A. and Apgar, C. and others},
  title   = {{Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment}},
  journal = {JAMA network open},
  year    = {2022},
  doi     = {10.1001/jamanetworkopen.2022.8392},
  pmid    = {35446396},
  url     = {https://doi.org/10.1001/jamanetworkopen.2022.8392}
}

@article{geldmacher2003-12834513,
  author  = {Geldmacher, D. S. and Provenzano, G. and McRae, T. and Mastey, V. and Ieni, JR.},
  title   = {{Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2003},
  doi     = {10.1046/j.1365-2389.2003.51306.x},
  pmid    = {12834513},
  url     = {https://doi.org/10.1046/j.1365-2389.2003.51306.x}
}

@article{dubois2012-22915447,
  author  = {Dubois, B. and Tolosa, E. and Katzenschlager, R. and Emre, M. and Lees, A. J. and Schumann, G. and Pourcher, E. and Gray, J. and others},
  title   = {{Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study}},
  journal = {Movement disorders : official journal of the Movement Disorder Society},
  year    = {2012},
  doi     = {10.1002/mds.25098},
  pmid    = {22915447},
  url     = {https://doi.org/10.1002/mds.25098}
}

@article{salvado2024-38514824,
  author  = {Salvadó, G. and Horie, K. and Barthélemy, N. R. and Vogel, J. W. and Pichet Binette, A. and Chen, C. D. and Aschenbrenner, A. J. and Gordon, B. A. and others},
  title   = {{Disease staging of Alzheimer's disease using a CSF-based biomarker model}},
  journal = {Nature aging},
  year    = {2024},
  doi     = {10.1038/s43587-024-00599-y},
  pmid    = {38514824},
  url     = {https://doi.org/10.1038/s43587-024-00599-y}
}

@article{weiner2015-26073027,
  author  = {Weiner, M. W. and Veitch, D. P. and Aisen, P. S. and Beckett, L. A. and Cairns, N. J. and Cedarbaum, J. and Green, R. C. and Harvey, D. and others},
  title   = {{2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2015},
  doi     = {10.1016/j.jalz.2014.11.001},
  pmid    = {26073027},
  url     = {https://doi.org/10.1016/j.jalz.2014.11.001}
}

@article{salvado2026-42189519,
  author  = {Salvadó, G. and Horie, K. and Barthélemy, N. R. and Schindler, S. E. and Janelidze, S. and Orduña Dolado, A. and Bali, D. and Perrin, R. J. and Morris, J. C. and Benzinger, T. L. S. and Gordon, B. A. and Stomrud, E. and others},
  title   = {{Plasma eMTBR-tau243 and \%p-tau217 for Biological Staging of Alzheimer Disease}},
  journal = {JAMA Neurology},
  year    = {2026},
  doi     = {10.1001/jamaneurol.2026.1405},
  pmid    = {42189519},
  url     = {https://doi.org/10.1001/jamaneurol.2026.1405}
}

@article{horie2023-37443334,
  author  = {Horie, K. and Salvadó, G. and Barthélemy, N. R. and Janelidze, S. and Li, Y. and He, Y. and Saef, B. and Chen, C. D. and others},
  title   = {{CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease}},
  journal = {Nature medicine},
  year    = {2023},
  doi     = {10.1038/s41591-023-02443-z},
  pmid    = {37443334},
  url     = {https://doi.org/10.1038/s41591-023-02443-z}
}

@article{kishnani2009-19606472,
  author  = {Kishnani, P. S. and Sommer, B. R. and Handen, B. L. and Seltzer, B. and Capone, G. T. and Spiridigliozzi, G. A. and Heller, J. H. and Richardson, S. and others},
  title   = {{The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome}},
  journal = {American journal of medical genetics. Part A},
  year    = {2009},
  doi     = {10.1002/ajmg.a.32953},
  pmid    = {19606472},
  url     = {https://doi.org/10.1002/ajmg.a.32953}
}

@article{berry2023-37040116,
  author  = {Berry, D. A. and Dhadda, S. and Kanekiyo, M. and Li, D. and Swanson, C. J. and Irizarry, M. and Kramer, L. D. and Berry, S. M.},
  title   = {{Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial}},
  journal = {JAMA network open},
  year    = {2023},
  doi     = {10.1001/jamanetworkopen.2023.7230},
  pmid    = {37040116},
  url     = {https://doi.org/10.1001/jamanetworkopen.2023.7230}
}

@article{horie2025-40164726,
  author  = {Horie, Kanta and Salvadó, Gemma and Koppisetti, Rama K. and Janelidze, Shorena and Barthélemy, Nicolas R. and He, Yingxin and Sato, Chihiro and Gordon, Brian Andrew and others},
  title   = {{Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer’s disease}},
  journal = {Nature Medicine},
  year    = {2025},
  doi     = {10.1038/s41591-025-03617-7},
  pmid    = {40164726},
  url     = {https://doi.org/10.1038/s41591-025-03617-7}
}

@article{rawal2025-40673737,
  author  = {Rawal, S. and Wildsmith, K. R. and Aluri, J. and Yagi, T. and Chang, M. K. and Niu, H. and Zhou, J. and Horie, K. and others},
  title   = {{An Anti-tau Therapeutic Antibody Etalanetug (E2814): A Phase 1, First-in-human (FIH) Study of Single and Multiple Ascending Doses in Healthy Subjects}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2025},
  doi     = {10.1097/wad.0000000000000680},
  pmid    = {40673737},
  url     = {https://doi.org/10.1097/wad.0000000000000680}
}

@article{wang2016-27010616,
  author  = {Wang, J. and Logovinsky, V. and Hendrix, S. B. and Stanworth, S. H. and Perdomo, C. and Xu, L. and Dhadda, S. and Do, I. and others},
  title   = {{ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials}},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  year    = {2016},
  doi     = {10.1136/jnnp-2015-312383},
  pmid    = {27010616},
  url     = {https://doi.org/10.1136/jnnp-2015-312383}
}

@article{tariot2001-11843990,
  author  = {Tariot, P. N. and Cummings, J. L. and Katz, I. R. and Mintzer, J. and Perdomo, C. A. and Schwam, E. M. and Whalen, E.},
  title   = {{A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2001},
  doi     = {10.1111/j.1532-5415.2001.49266.x},
  pmid    = {11843990},
  url     = {https://doi.org/10.1111/j.1532-5415.2001.49266.x}
}

@article{rogers2000-10793322,
  author  = {Rogers, S. L. and Doody, R. S. and Pratt, R. D. and Ieni, JR.},
  title   = {{Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study}},
  journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology},
  year    = {2000},
  doi     = {10.1016/s0924-977x(00)00067-5},
  pmid    = {10793322},
  url     = {https://doi.org/10.1016/s0924-977x(00)00067-5}
}

@article{rogers1998-9452942,
  author  = {Rogers, S. L. and Friedhoff, L. T.},
  title   = {{Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study}},
  journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology},
  year    = {1998},
  doi     = {10.1016/s0924-977x(97)00079-5},
  pmid    = {9452942},
  url     = {https://doi.org/10.1016/s0924-977x(97)00079-5}
}

@article{ritchie2016-26683239,
  author  = {Ritchie, C. W. and Molinuevo, J. L. and Truyen, L. and Satlin, A. and Van der Geyten, S. and Lovestone, S.},
  title   = {{Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project}},
  journal = {The lancet. Psychiatry},
  year    = {2016},
  doi     = {10.1016/s2215-0366(15)00454-x},
  pmid    = {26683239},
  url     = {https://doi.org/10.1016/s2215-0366(15)00454-x}
}

@article{vandyck2025-41355080,
  author  = {van Dyck, C. H. and Sperling, R. and Johnson, K. and Dhadda, S. and Kanekiyo, M. and Li, D. and Gee, M. and Hersch, S. and Irizarry, M. and Kramer, L.},
  title   = {{Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the Clarity AD open-label extension study}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70905},
  pmid    = {41355080},
  url     = {https://doi.org/10.1002/alz.70905}
}

@article{grill2024-37830926,
  author  = {Grill, J. D. and Flournoy, C. and Dhadda, S. and Ernstrom, K. and Sperling, R. and Molina-Henry, D. and Tranotti, K. and Harris, R. and others},
  title   = {{Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease}},
  journal = {Annals of neurology},
  year    = {2024},
  doi     = {10.1002/ana.26819},
  pmid    = {37830926},
  url     = {https://doi.org/10.1002/ana.26819}
}

@article{karlsson2025-41051312,
  author  = {Karlsson, Linda and Janelidze, Shorena and Barthélemy, Nicolas R. and Horie, Kanta and Therriault, Joseph and Gaetani, Lorenzo and Bellomo, Giovanni and Schindler, Suzanne Elizabeth and others},
  title   = {{Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers}},
  journal = {Brain},
  year    = {2025},
  doi     = {10.1093/brain/awaf375},
  pmid    = {41051312},
  url     = {https://doi.org/10.1093/brain/awaf375}
}

@article{grill2026-41910973,
  author  = {Grill, Joshua D. and RAMAN, REMA and Wang, Shunran and Ernstrom, Karin B. and Andrews, Patricia and Appleby, Brian Stephen and Bhangu, Jaspreet S. and Dhadda, Shobha and others},
  title   = {{Amyloid Imaging and APOE Genotype Disclosure and Short-Term Psychological Distress}},
  journal = {JAMA Network Open},
  year    = {2026},
  doi     = {10.1001/jamanetworkopen.2026.3845},
  pmid    = {41910973},
  url     = {https://doi.org/10.1001/jamanetworkopen.2026.3845}
}

@article{schindler2024-38866966,
  author  = {Schindler, S. E. and Galasko, D. and Pereira, A. C. and Rabinovici, G. D. and Salloway, S. and Suárez-Calvet, M. and Khachaturian, A. S. and Mielke, M. M. and Udeh-Momoh, C. and Weiss, J. and Batrla, R. and Bozeat, S. and others},
  title   = {{Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease}},
  journal = {Nature Reviews Neurology},
  year    = {2024},
  doi     = {10.1038/s41582-024-00977-5},
  pmid    = {38866966},
  url     = {https://doi.org/10.1038/s41582-024-00977-5}
}

@article{burns1999-10325453,
  author  = {Burns, A. and Rossor, M. and Hecker, J. and Gauthier, S. and Petit, H. and Möller, H. J. and Rogers, S. L. and Friedhoff, L. T.},
  title   = {{The effects of donepezil in Alzheimer's disease - results from a multinational trial}},
  journal = {Dementia and geriatric cognitive disorders},
  year    = {1999},
  doi     = {10.1159/000017126},
  pmid    = {10325453},
  url     = {https://doi.org/10.1159/000017126}
}

@article{vanmaurik2019-31526625,
  author  = {van Maurik, I. S. and Vos, S. J. and Bos, I. and Bouwman, F. H. and Teunissen, C. E. and Scheltens, P. and Barkhof, F. and Frolich, L. and others},
  title   = {{Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study}},
  journal = {The Lancet. Neurology},
  year    = {2019},
  doi     = {10.1016/s1474-4422(19)30283-2},
  pmid    = {31526625},
  url     = {https://doi.org/10.1016/s1474-4422(19)30283-2}
}

@article{chen2025-40189473,
  author  = {Chen, Christopher and Katayama, Sadao and Lee, Jae Hong and Lee, Jun-Young and Nakagawa, Masaki and Torii, Kentaro and Ogawa, Tomoo and Dash, Amitabh and others},
  title   = {{Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100160},
  pmid    = {40189473},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100160}
}

@article{ali2023-37101235,
  author  = {Ali, M. and Archer, D. B. and Gorijala, P. and Western, D. and Timsina, J. and Fernández, M. V. and Wang, T. C. and Satizabal, C. L. and others},
  title   = {{Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease}},
  journal = {Acta neuropathologica communications},
  year    = {2023},
  doi     = {10.1186/s40478-023-01563-4},
  pmid    = {37101235},
  url     = {https://doi.org/10.1186/s40478-023-01563-4}
}

@article{tahamimonfared2022-35286590,
  author  = {Tahami Monfared, A. A. and Byrnes, M. J. and White, L. A. and Zhang, Q.},
  title   = {{Alzheimer's Disease: Epidemiology and Clinical Progression}},
  journal = {Neurology and therapy},
  year    = {2022},
  doi     = {10.1007/s40120-022-00338-8},
  pmid    = {35286590},
  url     = {https://doi.org/10.1007/s40120-022-00338-8}
}

@article{lanctot2017-29067350,
  author  = {Lanctôt, K. L. and Amatniek, J. and Ancoli-Israel, S. and Arnold, S. E. and Ballard, C. and Cohen-Mansfield, J. and Ismail, Z. and Lyketsos, C. and others},
  title   = {{Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2017},
  doi     = {10.1016/j.trci.2017.07.001},
  pmid    = {29067350},
  url     = {https://doi.org/10.1016/j.trci.2017.07.001}
}

@article{jun2017-28183528,
  author  = {Jun, G. R. and Chung, J. and Mez, J. and Barber, R. and Beecham, G. W. and Bennett, D. A. and Buxbaum, J. D. and Byrd, G. S. and others},
  title   = {{Transethnic genome-wide scan identifies novel Alzheimer's disease loci}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2017},
  doi     = {10.1016/j.jalz.2016.12.012},
  pmid    = {28183528},
  url     = {https://doi.org/10.1016/j.jalz.2016.12.012}
}

@article{collij2026-41957377,
  author  = {Collij, Lyduine Eisa and Salvadó, Gemma and Horie, Kanta and Barthélemy, Nicolas R. and Betthauser, Tobey J. and Strandberg, Olof T. and Smith, Ruben A and Palmqvist, Sebastian and others},
  title   = {{Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer’s disease continuum}},
  journal = {Nature Communications},
  year    = {2026},
  doi     = {10.1038/s41467-026-71732-1},
  pmid    = {41957377},
  url     = {https://doi.org/10.1038/s41467-026-71732-1}
}

@article{hampel2023-37280110,
  author  = {Hampel, H. and Elhage, A. and Cho, M. and Apostolova, L. G. and Nicoll, J. A. R. and Atri, A.},
  title   = {{Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics}},
  journal = {Brain : a journal of neurology},
  year    = {2023},
  doi     = {10.1093/brain/awad188},
  pmid    = {37280110},
  url     = {https://doi.org/10.1093/brain/awad188}
}

@article{robinson2026-42191949,
  author  = {Robinson, Carling G. and Binette, Alexa Pichet and Horie, Kanta and Sato, Chihiro and Schindler, Suzanne Elizabeth and Bateman, Randall John and Benzinger, Tammie L.S. and Janelidze, Shorena and others},
  title   = {{Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in females}},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year    = {2026},
  doi     = {10.1007/s00259-026-07934-y},
  pmid    = {42191949},
  url     = {https://doi.org/10.1007/s00259-026-07934-y}
}

@article{moscoso2025-11860bf1,
  author  = {Moscoso, Alexis and Leuzy, Antoine and Raket, Lars Lau and Villemagne, Victor L. and Klein, Gregory and Tonietto, Matteo and Olafson, Emily and Baker, Suzanne L. and others},
  title   = {{External Validation of Joint Propagation Model‐Based Tau PET CenTauR units}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70856_106362},
  url     = {https://doi.org/10.1002/alz70856_106362}
}

@article{moscoso2025-41434902,
  author  = {Moscoso, Alexis and Leuzy, Antoine and Raket, Lars Lau and Villemagne, Victor L. and Klein, Gregory and Tonietto, Matteo and Olafson, Emily and Baker, Suzanne L. and others},
  title   = {{External Validation of Joint Propagation Model‐Based Tau PET CenTauR units}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70862_109722},
  pmid    = {41434902},
  url     = {https://doi.org/10.1002/alz70862_109722}
}

@article{toschi2019-31585366,
  author  = {Toschi, Nicola and Lista, Simone and Baldacci, Filippo and Cavedo, Enrica and Zetterberg, Henrik and Blennow, Kaj and Kilimann, Ingo and Teipel, Stefan Johannes and others},
  title   = {{Biomarker-guided clustering of Alzheimer's disease clinical syndromes}},
  journal = {Neurobiology of Aging},
  year    = {2019},
  doi     = {10.1016/j.neurobiolaging.2019.08.032},
  pmid    = {31585366},
  url     = {https://doi.org/10.1016/j.neurobiolaging.2019.08.032}
}

@article{zhou2025-41447712,
  author  = {Zhou, Jin and Andreozzi, Erica M. and Llibre‐Guerra, Jorge J. and Clifford, David B. and Li, David and Wang, Guoqiao and Schneider, Lon S. S. and McDade, Eric and others},
  title   = {{Safety of Lecanemab After 6‐Month Treatment in the DIAN‐TU‐001 Trial}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70859_105304},
  pmid    = {41447712},
  url     = {https://doi.org/10.1002/alz70859_105304}
}

@article{haji2025-40484799,
  author  = {Haji, Babak and Zhang, Quanwu and Monfared, Amir Abbas Tahami},
  title   = {{Bridging the gap: A conversion framework for CDR-SB and MoCA scores in Alzheimer's disease and related dementia}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100226},
  pmid    = {40484799},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100226}
}

@article{wildsmith2025-41447716,
  author  = {Wildsmith, Kristin R. and Charil, Arnaud and Benzinger, Tammie L.S. and Gordon, Brian Andrew and Bhagunde, Pratik R. and Li, David and Wang, Guoqiao and Reyderman, Larisa and others},
  title   = {{Lecanemab in DIAD: 6‐Month Amyloid PET Results from the DIAN‐TU‐001 Trial}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70859_105303},
  pmid    = {41447716},
  url     = {https://doi.org/10.1002/alz70859_105303}
}

@article{tahamimonfared2022-35192176,
  author  = {Tahami Monfared, A. A. and Byrnes, M. J. and White, L. A. and Zhang, Q.},
  title   = {{The Humanistic and Economic Burden of Alzheimer's Disease}},
  journal = {Neurology and therapy},
  year    = {2022},
  doi     = {10.1007/s40120-022-00335-x},
  pmid    = {35192176},
  url     = {https://doi.org/10.1007/s40120-022-00335-x}
}

@article{llibreguerra2025-41450326,
  author  = {Llibre‐Guerra, Jorge J. and Zhou, Jin and Schneider, Lon S. S. and Andreozzi, Erica M. and Clifford, David B. and Banerjee, Sibabrata and Wang, Guoqiao and McDade, Eric and others},
  title   = {{Baseline Participant Characteristics in the DIAN‐TU‐001 Trial}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70859_105299},
  pmid    = {41450326},
  url     = {https://doi.org/10.1002/alz70859_105299}
}

@article{sabbagh2020-32463070,
  author  = {Sabbagh, M. N. and Boada, M. and Borson, S. and Doraiswamy, P. M. and Dubois, B. and Ingram, J. and Iwata, A. and Porsteinsson, A. P. and others},
  title   = {{Early Detection of Mild Cognitive Impairment (MCI) in an At-Home Setting}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2020},
  doi     = {10.14283/jpad.2020.22},
  pmid    = {32463070},
  url     = {https://doi.org/10.14283/jpad.2020.22}
}

@article{collij2025-41443949,
  author  = {Collij, Lyduine Eisa and Salvadó, Gemma and Horie, Kanta and Barthélemy, Nicolas R. and Betthauser, Tobey J. and Strandberg, Olof T. and Smith, Ruben A and Palmqvist, Sebastian and others},
  title   = {{Trajectories of CSF and plasma MTBR‐tau 243 and phosphorylated‐tau species across the Alzheimer's disease continuum}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70856_098557},
  pmid    = {41443949},
  url     = {https://doi.org/10.1002/alz70856_098557}
}

@article{frech2025-40704847,
  author  = {Frech, Feride H. and Li, Gang and Juday, Timothy R. and Ding, Yingjie and Mattke, Soeren and Khachaturian, Ara S. and Rosenberg, Aaron Seth and Ndiba-Markey, Colette and others},
  title   = {{Real-world health care costs and resource utilization associated with mild cognitive impairment in the United States: A retrospective cohort study of commercial and Medicare data}},
  journal = {Journal of Managed Care \& Specialty Pharmacy},
  year    = {2025},
  doi     = {10.18553/jmcp.2025.31.8.782},
  pmid    = {40704847},
  url     = {https://doi.org/10.18553/jmcp.2025.31.8.782}
}

@article{chung2018-29274321,
  author  = {Chung, J. and Wang, X. and Maruyama, T. and Ma, Y. and Zhang, X. and Mez, J. and Sherva, R. and Takeyama, H. and others},
  title   = {{Genome-wide association study of Alzheimer's disease endophenotypes at prediagnosis stages}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2018},
  doi     = {10.1016/j.jalz.2017.11.006},
  pmid    = {29274321},
  url     = {https://doi.org/10.1016/j.jalz.2017.11.006}
}

@article{zhang2024-39699743,
  author  = {Zhang, Haixin and Monfared, Amir Abbas Tahami and Zhang, Quanwu and Honig, Lawrence S.},
  title   = {{Incidence and Prevalence of Alzheimer’s Disease in Medicare Beneficiaries}},
  journal = {Neurology and Therapy},
  year    = {2024},
  doi     = {10.1007/s40120-024-00695-6},
  pmid    = {39699743},
  url     = {https://doi.org/10.1007/s40120-024-00695-6}
}

@article{robinson2025-41443270,
  author  = {Robinson, Carling G. and Binette, Alexa Pichet and Horie, Kanta and Sato, Chihiro and Schindler, Suzanne Elizabeth and Barthélemy, Nicolas R. and Bateman, Randall John and Benzinger, Tammie L.S. and others},
  title   = {{Associations between tau PET and CSF MTBR243 do not vary by sex}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70856_098213},
  pmid    = {41443270},
  url     = {https://doi.org/10.1002/alz70856_098213}
}

@article{monfared2025-41433980,
  author  = {Monfared, Amir Abbas Tahami and Zhang, Raymond J. and Zhang, Quanwu and Gao, Ran and Haji, Babak},
  title   = {{Lecanemab adoption and geographic variation among patients with diagnosis of mild cognitive impairment or Alzheimer's dementia in Medicare fee‐for‐service beneficiaries}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70860_106870},
  pmid    = {41433980},
  url     = {https://doi.org/10.1002/alz70860_106870}
}

@article{bhagunde2026-41543367,
  author  = {Bhagunde, Pratik R. and Penner, Natasha and Willis, Brian A. and Bell, Robert and Charil, Arnaud and Irizarry, Michael C. and Hersch, Steven J. and Reyderman, Larisa},
  title   = {{Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR ‐ SB Utilizing Semi‐Mechanistic Model}},
  journal = {CPT Pharmacometrics \& Systems Pharmacology},
  year    = {2026},
  doi     = {10.1002/psp4.70173},
  pmid    = {41543367},
  url     = {https://doi.org/10.1002/psp4.70173}
}

@article{benzinger2025-41447186,
  author  = {Benzinger, Tammie L.S. and Charil, Arnaud and Gordon, Brian Andrew and Flores, Shaney E. and Hornbeck, Russ C. and Wildsmith, Kristin R. and Banerjee, Sibabrata and Wang, Guoqiao and others},
  title   = {{Baseline Imaging Characteristics of Participants in the Phase II/III DIAN‐TU‐001 Tau NexGen Trial for Dominantly Inherited Alzheimer’s Disease}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70859_105301},
  pmid    = {41447186},
  url     = {https://doi.org/10.1002/alz70859_105301}
}

@article{doherty2022-35622461,
  author  = {Doherty, T. and Gee, M. and Maruff, P. and Smith, R. and Murphy, J. and Marsh, J. and Koschalka, L. and Martinez, M. and others},
  title   = {{Increasing the Cognitive Screening Efficiency of Global Phase III Trials in Early Alzheimer Disease: The Cognitive Task Force}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2022},
  doi     = {10.1097/wad.0000000000000508},
  pmid    = {35622461},
  url     = {https://doi.org/10.1097/wad.0000000000000508}
}

@article{zhang2023-28dad969,
  author  = {Zhang, Haixin and Zhang, Quanwu and Monfared, Amir Abbas Tahami},
  title   = {{Prevalence of Alzheimer’s disease (AD) dementia and mild cognitive impairment (MCI) in the United States Medicare population}},
  journal = {Alzheimer s \& Dementia},
  year    = {2023},
  doi     = {10.1002/alz.077079},
  url     = {https://doi.org/10.1002/alz.077079}
}

@article{zhang2023-6c84f580,
  author  = {Zhang, Haixin and Zhang, Quanwu and Monfared, Amir Abbas Tahami},
  title   = {{Incidence of Alzheimer’s disease (AD) dementia and mild cognitive impairment (MCI) in the United States Medicare population}},
  journal = {Alzheimer s \& Dementia},
  year    = {2023},
  doi     = {10.1002/alz.077092},
  url     = {https://doi.org/10.1002/alz.077092}
}